Home
Conditions
Ureter Cancer

Clinical trial condition

Ureter Cancer

Explore clinical trials studying Ureter Cancer. Study availability and eligibility vary by location and protocol.

24 public trials 6 recruiting studies

Refine in advanced search Browse all conditions

Ureter Cancer trial results

Completed

A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer

NCT01326871

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +20 more
Locations: The University of Arizona Cancer Center Tucson, Arizona, United States

UF Health Center at Orlando Health Orlando, Florida, United States

Martin Health System Stuart, Florida, United States

H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View all 16 locations

View Trial Details

Completed

Study Comparing Denosumab With Standard Treatment in Urothelial Cancer Patients With Bone Metastases

NCT03520231

Conditions: Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +20 more
Locations: Princess Margaret Cancer Centre Toronto, Ontario, Canada

View Trial Details

Completed

Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers

NCT01846520

Conditions: Adenocarcinoma, Adnexal Diseases, Carcinoma, +137 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Completed

A Trial With Vinflunine in Patients With Metastatic Bladder Cancer and Impaired Renal Function

NCT02665039

Conditions: Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +21 more
Locations: Department of Oncology, Rigshospitalet Copenhagen, Denmark

Department of Oncology, Karolinska University Hospital Stockholm, Sweden

View Trial Details

Completed

Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer

NCT02300610

Conditions: Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +20 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

University of Minnesota, Masonic Cancer Center Minneapolis, Minnesota, United States

View Trial Details

Completed

Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract Cancer

NCT01191892

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +16 more
Locations: Beatson West of Scotland Cancer Centre Glasgow, Scotland, United Kingdom

Wales Cancer Trials Unit Cardiff, Wales, United Kingdom

Ayr Hospital Ayr, United Kingdom

Royal Bournemouth General Hospital Bournemouth, United Kingdom

View all 21 locations

View Trial Details

Completed

Phase I Study With Sorafenib in Addition to Vinflunine in Metastatic Transitional Cell Carcinoma of the Urothelial Tract

NCT01844947

Conditions: Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +21 more
Locations: Department of Oncology, Aarhus University Hospital Aarhus, Denmark

Department of Oncology, Rigshospitalet Copenhagen, Denmark

Department of Oncology, Karolinska University Hospital Stockholm, Sweden

View Trial Details

Completed

CLE Characteristics of Upper Urinary Tract Urothelial Carcinoma

NCT03013920

Conditions: Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +15 more
Locations: Academic Medical Center Amsterdam, Netherlands

View Trial Details

Completed

TRC105 in Adults With Advanced/Metastatic Urothelial Carcinoma

NCT01328574

Conditions: Cancer of the Ureter, Carcinoma, Carcinoma, Transitional Cell, +18 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Gemcitabine and Split-Dose Cisplatin Plus Everolimus (RAD001) in Patients With Advanced Solid Tumor Malignancies

NCT01182168

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Ureter Cancer

Ureter Cancer trial results

Related conditions